BuyInsider
KENYON LAWRENCE A — buy in Outlook Therapeutics, Inc.
Officer (Chief Financial Officer), Director
101,010 shares · code P
View SEC EDGAR filing →Form 4 insider tape
OTLK
Live SEC EDGAR Form 4 buys and sells for OTLK · 3 buys / 0 sells in this slice. Structured filings only — no AI rewrite. Informational — not investment advice.
BuyInsider
Jahr Robert Charles — buy in Outlook Therapeutics, Inc.
Officer (Chief Executive Officer), Director
151,515 shares · code P
View SEC EDGAR filing →BuyInsider
Sukhtian Ghiath M. — buy in Outlook Therapeutics, Inc.
2,525,252 shares @ $0.99 · ~$2.5M · code P
View SEC EDGAR filing →